I would also like to point out that it's not just a question of additional funding, but it could also be changing the way they carry out their regulatory activities. We didn't look at it specifically in this report, but we did an audit of the regulation of medical devices about two years ago. One of the recommendations we made was that they might want to do more work in harmonizing with other countries, rather than Canada always conducting all of the reviews. Perhaps they could rely on reviews done by others and focus more on the post-market activities, which is the testing and the reporting. So there could be ways that they change how they carry out regulatory activities.
But again it comes back to knowing what the department feels they should be doing in order to meet those regulatory responsibilities. Then the funding is obviously a consequence of that.